Hydrolysis of myelin basic protein by polyclonal catalytic IgGs from the sera of patients with multiple sclerosis

Journal of Cellular and Molecular Medicine

Volumn 8, Issue 3, 2004, Pages 359-368

  Polosukhina, Darya I ^a   Kanyshkova, Tatyana G ^a   Doronin, Boris M ^b   Tyshkevich, Olga B ^b   Buneva, Valentina N ^a   Boiko, Alexey N ^c   Gusev, Evgenii I ^c   Favorova, Olga O ^c   Nevinsky, Georgy A ^a  

^a INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE   (Russian Federation)

^b NOVOSIBIRSK STATE MEDICAL UNIVERSITY   (Russian Federation)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Catalytic IgG; Human blood; Hydrolysis of myelin basic protein; Multiple sclerosis

Indexed keywords

AUTOANTIBODY; CATALYTIC ANTIBODY; IMMUNOGLOBULIN G; MYELIN BASIC PROTEIN; PROTEINASE INHIBITOR;

ADOLESCENT; ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; HYDROLYSIS; IMMUNOLOGY; IN VITRO STUDY; MALE; METABOLISM; MIDDLE AGED; MULTIPLE SCLEROSIS;

ADOLESCENT; ADULT; ANTIBODIES, CATALYTIC; AUTOANTIBODIES; FEMALE; HUMANS; HYDROLYSIS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PROTEASE INHIBITORS;

EID: 20644470832     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2004.tb00325.x     Document Type: Article

References (55)

1. Suzuki H., Recent advances in abzyme studies, J. Biochem. (Tokyo), 115: 623-628, 1994
2. Tramontano A., Gololobov G., Paul S., Proteolytic antibodies: origins, selection and induction. Chem. Immunol., 77: 1-17, 2000
3. Gololobov G., Tramontano A., Paul S. Nucleophilic proteolytic antibodies. Appl. Biochem. Biotechnol., 83: 221-231, 2000
4. Nevinsky G.A., Kanyshkova T.G., Buneva V.N. Natural catalytic antibodies (abzymes) in normalcy and pathology. Biochemistry (Moscow), 65: 1245-1255, 2000
5. Nevinsky G.A., Favorova O.O., Buneva V.N. Natural Catalytic Antibodies - New Characters in the Protein Repertoire. In: E. Golemis, eds. Protein-protein interactions; a molecular cloning manual. Cold Spring Harbor Lab. Press, Cold Spring Harbor, New York, 2002, pp. 523-534
6. Nevinsky G.A., Buneva V.N. Human catalytic RNA- and DNA-hydrolyzing antibodies, J. Immunol. Methods, 269: 235-245, 2002
7. Nevinsky G.A., Buneva V.N. Catalytic antibodies in healthy humans and patients with autoimmune and viral pathologies, J. Cell. Mol. Med., 7: 265-276, 2003
8. Paul S., Volle D.J., Beach C.M., Johnson D.R., Powell M.J., Massey R.J., Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody, Science, 244: 1158-1162, 1989
9. Shuster A.M., Gololobov G.V., Kvashuk O.A., Bogomolova A.E., Smirnov I.V., Gabibov A.G., DNA hydrolyzing autoantibodies, Science, 256: 665-667, 1992
10. Buneva V.N., Andrievskaia O.A., Romannikova I.V., Gololobov G.V., Iadav R.P., Iamkovoi V.I., Nevinskii G.A., Interaction of catalytically active antibodies with oligoribonucleotides. Mol. Biol. (Moscow), 28: 738-743, 1994
11. Andrievskaya O.A., Buneva V.N., Naumov V.A., Nevinsky G.A. Catalytic heterogeneity of polyclonal RNA-hydrolyzing IgM from sera of patients with lupus erythematosus. Med. Sci. Monit., 6: 460-470, 2000
12. Andrievskaya O.A., Buneva V.N., Baranovskii A.G., Gal'vita A.V., Benzo E.S., Naumov V.A., Nevinsky G.A., Catalytic diversity of polyclonal RNA-hydrolyzing IgG antibodies from the sera of patients with lupus erythematosus, Immunol. Lett., 81: 191-198, 2002
13. Vlassov A., Florentz C., Helm M., Naumov V., Buneva V., Nevinsky G., Giege R., Characterization and selectivity of catalytic antibodies from human serum with RNase activity, Nucl. Acid Research, 26: 5243-5250, 1998
14. Vlassov A.V., Baranovskii A.G., Kanyshkova T.G., Prints A.V., Zabara V.G., Naumov V.A., Breusov A.A., Buneva V.N., Nevinsky G.A., Substrate specificity of DNA- and RNA-hydrolyzing antibodies from blood of patients with polyarthritis and Hashimoto's thyroiditis. Mol. Biol. (Moscow), 32: 559-569, 1998
15. Baranovsky, A.G., Matushin V.G., Vlassov A.V., Zabara V.G., Naumov V.A., Buneva, V.N., Nevinsky G.A., DNA- and RNA-hydrolyzing antibodies from the blood of patients with various forms of viral hepatitis, Biochemistry (Moscow), 62: 1358-1366, 1997
16. Kozyr A.V., Kolesnikov A., Aleksandrova E.S., Sashchenko L.P., Gnuchev N., Favorov P.V., Kotelnikov M.A., Iakhnina E.I., Astsaturov I.A., Prokaeva T.B., Alekberova Z.S., Suchkov S.V., Gabibov A.G., Novel functional activities of anti-DNA autoantibodies from sera of patients with lymphoproliferative and autoimmune diseases. Appl. Biochem. Biotechnol., 75: 45-61, 1998
17. Gololobov G.V., Mikhalap S.V., Starov A.V., Kolesnikov A.F., and Gabibov A. G. Natural targets for DNA-hydrolyzing antibodies Appl. Biochem. Biotechnol., 47, 305-314, 1994
18. Neustoev K.N., Ivanen D.R., Kulminskaya A.A., Brumer I.H., Saveliev A.N., Nevinsky G.A. Amylolytic activity and catalytic properties of IgM and IgG antibodies from patients with systemic lupus erythematosus. Human antibodies, 12: 31-34, 2003
19. Savel'ev A.N., Eneyskaya E.V., Shabalin K.A., Filatov M.V., Neustroev K.N., Antibodies with amylolytic activity. Protein Peptide Lett., 6: 179-184, 1999
20. Li L., Paul S., Tyutyulkova S. Kazatchkine M.D., and Kaveri S. Catalytic activity of anti-thyroglobulin antibodies. J. Immunol., 154: 3328-3332, 1995
21. Kalaga R., Li L., O'Dell J.R., Paul S., Unexpected presence of polyreactive catalytic antibodies in IgG from unimmunized donors and decreased levels in rheumatoid arthritis. J. Immunol., 155: 2695-2702, 1995
22. Matsuura K., Ikoma S., Sugiyama M., Funauchi M., Sinohara H., Amidase and peptidase activities of polyclonal immunoglobulin G present in the sera of patients with rheumatoid arthritis. Appl. Biochem. Biotechnol., 83: 107-113, 2000
23. Lacroix-Desmazes S., Moreau A., Sooryanarayana A., Bonnemain C., Stieltjes N., Pashov A., Sultan Y., Hoebeke J., Kazatchkine M.D., Kaveri S.V., Catalytic activity of antibodies against factor VIII in patients with hemophilia A. Nat. Med., 5: 1044-1047, 1999
24. Sinohara H., Matsuura K., Does catalytic activity of Bens-Jones proteins contribute to the pathogenesis of multiple myeloma? Appl. Biochem. Biotechnol., 83: 85-94, 2000
25. Paul S., Kalaga R.S., Gololobov G., Brenneman D., Natural catalytic immunity is not restricted to autoantigenic substrates: identification of a human immunodeficiency virus gp 120- cleaving antibody light chain, Appl. Biochem. Biotechnol., 83: 71-82, 2000
26. Kanyshkova T.G., Semenov D.V., Khlimankov D.Y., Buneva V.N., Nevinsky G.A., DNA-hydrolyzing activity of the light chain of IgG antibodies from milk of healthy human mothers, FEBS Lett., 416: 23-26, 1997
27. Nevinsky G.A., Kanyshkova T.G., Semenov D.V., Vlassov A.V., Gal'vita A.V., Buneva V.N., Secretory immunoglobulin A from healthy human mothers' milk catalyzes nucleic acid hydrolysis, Appl. Biochem. Biotechnol., 83: 115-129, 2000
28. Buneva V.N., Kanyshkova T.G., Vlassov A.V., Semenov D.V., Khlimankov D., Breusova L.R., Nevinsky G.A., Catalytic DNA- and RNA-hydrolyzing antibodies from milk of healthy human mothers, Appl. Biochem. Biotechnol., 75: 63-76, 1998
29. Semenov D.V., Kanyshkova T.G., Kit Y.Y., Khlimankov D.Y., Akimzhanov A.M., Gorbunov D.A., Buneva V.N., Nevinsky G.A., Human breast milk immunoglobulins G hydrolyze nucleotides, Biochemistry (Moscow), 63: 935-943, 1998
30. Semenov D.V., Kanyshkova T.G., Karotaeva N.A., Krasnorutskii M.A., Kuznetsova I.A., Buneva V.N., Nevinsky G.A. Catalytic nucleotide-hydrolyzing antibodies in milk and serum of clinically healthy human mothers. Med. Sci. Monit., 10: BR23-BR33, 2004
31. Kit Y.Y., Semenov D.V., Nevinsky G.A., Phosphorylation of different human milk proteins by immunoglobulin A. Bioch. Mol. Biol. Internat., 39: 521-527, 1996
32. Nevinsky G.A., Kit Y., Semenov D.V., Khlimankov D., Buneva V.N., Secretory immunoglobulin A from human milk catalyzes milk protein phosphorylation, Appl. Biochem. Biotechnol., 75: 77-91, 1998
33. Savel'ev A.N., Kanyshkova T.G., Kulminskaya A.A., Buneva V.N., Eneyskaya E.V., Filatov M.V., Nevinsky G.A., Neustroev K.N., Amylolytic activity of IgG and sIgA immunoglobulins from human milk, Clin. Chim. Acta, 314: 141-152, 2001
34. Boiko A.N., Favorova O.O., Multiple sclerosis: molecular and cellular mechanisms. Mol. Biol. (Mosk). 29: 727-749, 1995
35. O'Connor, K.C., Bar-Or, A., Hafler D.A. Neuroimmunology of multiple sclerosis, J. Clin. Immunol. 21:81-92, 2001
36. Archelos J.J., Storch M.K., Hartung H.P., The role of B cells and autoantibodies in multiple sclerosis. Ann. Neurol. 47: 694-706, 2000
37. Hemmer B., Archelos J.J., Hartung H.P., New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci., 3: 291-301, 2002
38. Cross A.H., Trotter J.L., Lyons J. B cells and antibodies in CNS demyelinating disease, J. Neuroimmunol.; 112: 1-14, 2001
39. Baranovskii A.G., Kanyshkova T.G., Mogelnitskii A.S., Naumov V.A., Buneva V.N., Gusev E.I., Boiko A.N., Zargarova T.A., Favorova O.O., Nevinsky G.A., Polyclonal antibodies from blood and cerebrospinal fluid of patients with multiple sclerosis effectively hydrolyze DNA and RNA. Biochemistry (Moscow), 63: 1239-1248, 1998
40. Baranovskii A.G., Ershova N.A., Buneva V.N., Kanyshkova T.G., Mogelnitskii A.S., Doronin B.M., Boiko A.N., Gusev E.I., Favorova O.O., and Nevinsky G.A. Catalytic heterogeneity of polyclonal DNA-hydrolyzing antibodies from the sera of patients with multiple sclerosis. Immunol. Lett., 76: 163-167, 2001
41. Saveliev A.N., Ivanen D.R., Kulminskaya A.A., Ershova N.A., Kanyshkova T.G., Buneva V.N., Mogelnitskii A.S., Doronin B.M., Favorova O.O., Nevinsky G.A., Neustroev K. Amylolytic activity of IgM and IgG antibodies from patients with multiple sclerosis. Immunol. Lett., 86: 291-297, 2003
42. Ponomarenko N.A., Durova O.M., Vorobiev I.I., Aleksandrova E.S., Telegin G.B., Chamborant O.G., Sidorik L.L., Suchkov S.V., Alekberova Z.S., Gnuchev N.V., Gabibov A.G. Catalytic antibodies in clinical and experimental pathology: human and mouse models. J. Immunol. Methods, 269:197-211, 2002
43. Deibler G.E., Boud L.F., Kies M.W. Enzymatic and nonemzymatic degradation of myelin basic protein. Neurochem. Research, 9: 1371-1385, 1984
44. Poser C.M. The diagnosis of multiple sclerosis. Thieme-Stratton NY, 1984, pp. 3-13
45. Wurster U., Demonstration of oligoclonal IgG in the unconcentretrated CSF by silver stain, in Stathakos G (ed): Proceedings of the Intern. Conference on Electrophoresis, Electroforesis'82. Berlin, New York, 1983, pp. 249-258
46. Towbin H., Stachelin T., Gordon J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA, 76: 4350-4354, 1979
47. Reindl M., Linington C., Brehm U., Egg, R., Dilitz E., Deisenhammer F., Poewe W., Berger T. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study, Brain, 122:2047-2056, 1999
48. Terryberry J.W., Thor G., Peter J.B. Autoantibodies in neurodegenerative diseases: Antigen-specific frequencies and intrathecal analysis. Neurobiol Aging, 19:205-216, 1998
49. Brokstad K.A., Page M., Nyland H., Haaheim L.R. Autoantibodies to myelin basic protein are not present in the serum and CSF of MS patients. Acta Neurol. Scand., 89:407-411, 1994
50. Olsson T., Baig S., Hojeberg B., Link H., Antimyelin basic protein and antimyelin antibody-producing cells in multiple sclerosis, Ann. Neurol., 27:132-136, 1990
51. Colombo E., Banki K., Tatum A.H., Daucher J., Ferrante P., Murray R.S., Phillips P.E., Perl A., Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis, J. Clin. Invest., 99:1238-1250, 1997
52. Kamholz J., de Ferra F., Pukkett C., Lazzarini R. Indentification of three forms of human myelin basic protein by cDNA cloning, Proc. Natl. Acad. Sci. USA, 83: 4962-4966, 1986
53. Enshtein E. The proteins of brain and cerebrospinal fluid in norm and pathology, Myr, Moscow, 1988
54. Paul S. Mechanism and functional role of antibody catalysis. Appl. Biochem. Biotechnol., 75: 13-23, 1998
55. Williamson R.A., Burgoon M.P., Owens G.P., Ghausi O., Leclerc E., Firme L., Carlson S., Corboy J., Parren P.W., Sanna P.P., Gilden D.H., and Burton D.R., Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis, Proc. Natl. Acad. Sci. USA, 98: 1793-1798, 2001